| |
| |
|
| Insider
Information: |
Mcavoy David R. |
| Relationship: |
Gen Counsel, CCO, & Se... |
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,061 |
|
|
Indirect Shares
|
310 |
|
|
| Direct
Value |
$10,857 |
|
|
|
Indirect Value
|
$210 |
|
|
| Total
Shares |
16,371 |
|
|
| Total
Value |
$11,067 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
General Counsel |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Gen Counsel, CCO, & Se... |
2023-10-02 |
16,061 |
2023-10-02 |
310 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FRTX |
Fresh Tracks Therapeutics... |
Gen Counsel, CCO, & Secretary |
• – – |
2023-10-02 |
4 |
D |
$0.98 |
$7,209 |
D/D |
(7,358) |
16,061 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Gen Counsel, CCO, & Secretary |
• – – |
2023-10-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
23,419 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2021-07-23 |
4 |
B |
$0.67 |
$12,138 |
D/D |
18,124 |
128,879 |
2.74 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2021-05-17 |
4 |
B |
$0.80 |
$6,384 |
I/I |
7,980 |
13,980 |
1.99 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2021-05-17 |
4 |
B |
$0.80 |
$14,898 |
D/D |
18,622 |
110,755 |
2.74 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2021-03-16 |
4 |
D |
$1.14 |
$9,975 |
D/D |
(8,750) |
92,133 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2021-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
100,883 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2020-09-18 |
4 |
B |
$0.84 |
$5,039 |
I/I |
6,000 |
6,000 |
1.99 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2020-09-18 |
4 |
B |
$0.83 |
$13,713 |
D/D |
16,526 |
75,883 |
2.74 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel and CCO |
• – – |
2020-06-22 |
4 |
B |
$0.00 |
$0 |
D/D |
30,435 |
59,357 |
2.66 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
General Counsel |
• – – |
2019-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,922 |
|
- |
|
| ECYT |
Endocyte Inc |
General Counsel |
• – – |
2018-12-21 |
4 |
D |
$24.00 |
$620,856 |
D/D |
(25,869) |
0 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
